Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
Inflammatory Response01:28

Inflammatory Response

14.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
14.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

277
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
277
Autoimmune Disorders01:29

Autoimmune Disorders

1.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

8.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgA autoantibodies promote inflammation, Th17 polarization and fibrotic responses in hidradenitis suppurativa.

Nature communications·2026
Same author

Dysregulation of U12-Type Splicing in Lupus Neutrophils.

bioRxiv : the preprint server for biology·2025
Same author

Phospholipid scramblases TMEM16F and Xkr8 mediate distinct features of phosphatidylserine (PS) externalization and immune suppression to promote tumor growth.

Cell death discovery·2025
Same author

Establishing Tyro3, Axl, and Mertk Chinese hamster ovary (CHO) reporter cell lines for cancer immunology and therapeutic applications.

Methods in cell biology·2025
Same author

Immunometabolism in systemic lupus erythematosus.

Nature reviews. Rheumatology·2025
Same author

Next generation sequencing analysis reveals complex genetic architecture of childhood-onset systemic lupus erythematosus.

Lupus science & medicine·2025
Same journal

Time to rethink the treatment of palindromic rheumatism.

Nature reviews. Rheumatology·2026
Same journal

Sensory nerves protect against tendon degeneration.

Nature reviews. Rheumatology·2026
Same journal

Publisher Correction: TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026
Same journal

TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026
Same journal

Lung disease in rheumatoid arthritis.

Nature reviews. Rheumatology·2026
Same journal

Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis.

Nature reviews. Rheumatology·2026
See all related articles

Related Experiment Video

Updated: Nov 8, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.6K

Interferon lambda in inflammation and autoimmune rheumatic diseases.

Rishi R Goel1,2, Sergei V Kotenko3, Mariana J Kaplan4

  • 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. rishi.goel@pennmedicine.upenn.edu.

Nature Reviews. Rheumatology
|April 28, 2021
PubMed
Summary
This summary is machine-generated.

Type III interferons (IFNλs) show complex immune roles beyond antiviral defense. Elevated IFNλ levels in autoimmune diseases suggest a potential role in pathogenesis and may inform new treatment strategies.

More Related Videos

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

10.3K
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.9K

Related Experiment Videos

Last Updated: Nov 8, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.6K
Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

10.3K
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.9K

Area of Science:

  • Immunology
  • Cytokine Biology
  • Autoimmune Disease Research

Background:

  • Interferons (IFNs) are crucial cytokines modulating immunity against infections.
  • Type I IFNs (IFNα, IFNβ) are implicated in autoimmune disease pathogenesis.
  • Type III IFNs (IFNλs) were initially known for epithelial antiviral defense but have broader immune effects.

Purpose of the Study:

  • To critically evaluate the literature on IFNλ biology in autoimmunity.
  • To explore the contribution of IFNλs to immune dysregulation and tissue damage in autoimmune diseases.
  • To consider the implications of IFNλs for treatment strategies in autoimmune rheumatic diseases.

Main Methods:

  • Literature review of current research on IFNλ biology.
  • Analysis of studies investigating IFNλ levels in autoimmune rheumatic diseases.
  • Evaluation of the role of IFNλs in innate and adaptive immune responses.

Main Results:

  • IFNλs exhibit complex roles in both innate and adaptive immunity.
  • Increased IFNλ concentrations are observed in blood and tissues of patients with autoimmune rheumatic diseases.
  • Elevated IFNλ levels correlate with specific clinical and laboratory parameters in these diseases.

Conclusions:

  • IFNλs may play a pathogenic role in systemic autoimmune diseases.
  • Understanding IFNλ biology is crucial for elucidating immune dysregulation in autoimmunity.
  • Targeting IFNλ pathways could represent a novel therapeutic approach for autoimmune rheumatic diseases.